Neuralink Completes Third Brain Implant, Plans for Expanded Trials in 2025

Elon Musk announces successful brain-computer interface implants with upgraded features, aiming to enroll 20-30 more patients this year.

Neuralink has successfully implanted its brain-computer interface device in a third human patient, marking continued progress in its clinical trials.
The company plans to expand its trials in 2025, targeting 20-30 additional patients, primarily focusing on individuals with spinal cord injuries.
The device, known as Link, now features more electrodes, higher bandwidth, and longer battery life, allowing for improved functionality and user experience.
Previous recipients of the implant have demonstrated the ability to play video games and use advanced software, showcasing its potential to restore digital independence for those with paralysis.
Neuralink operates in a competitive brain-computer interface field, with over 45 trials underway globally and other companies exploring less invasive or versatile approaches.